Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 14, 2024

SELL
$191.51 - $216.16 $1.27 Million - $1.44 Million
-6,640 Reduced 5.88%
106,205 $22.5 Million
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $1.27 Million - $1.44 Million
-6,640 Reduced 5.88%
106,205 $22.5 Million
Q2 2023

Feb 14, 2024

BUY
$187.64 - $206.25 $21.2 Million - $23.3 Million
112,845 New
112,845 $21.7 Million
Q2 2023

Aug 10, 2023

BUY
$187.64 - $206.25 $12.6 Million - $13.8 Million
66,992 Added 146.1%
112,845 $21.7 Million
Q1 2023

May 11, 2023

BUY
$127.59 - $203.08 $526,946 - $838,720
4,130 Added 9.9%
45,853 $9.28 Million
Q4 2022

Feb 07, 2023

BUY
$117.37 - $139.17 $1.29 Million - $1.53 Million
10,994 Added 35.78%
41,723 $5.36 Million
Q3 2022

Nov 09, 2022

SELL
$135.27 - $180.11 $75,074 - $99,961
-555 Reduced 1.77%
30,729 $4.2 Million
Q2 2022

Aug 11, 2022

BUY
$108.81 - $179.33 $148,634 - $244,964
1,366 Added 4.57%
31,284 $5.53 Million
Q1 2022

May 09, 2022

BUY
$119.61 - $157.85 $294,719 - $388,942
2,464 Added 8.98%
29,918 $4.31 Million
Q4 2021

Feb 04, 2022

BUY
$142.57 - $190.86 $1.31 Million - $1.75 Million
9,155 Added 50.03%
27,454 $4.25 Million
Q3 2021

Nov 08, 2021

SELL
$142.45 - $169.82 $11.9 Million - $14.2 Million
-83,516 Reduced 82.03%
18,299 $3.11 Million
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $13.8 Million - $16.4 Million
101,815 New
101,815 $16.1 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.